Resham Bhattacharya

13.9k total citations · 3 hit papers
122 papers, 9.2k citations indexed

About

Resham Bhattacharya is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Resham Bhattacharya has authored 122 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 39 papers in Biomaterials and 26 papers in Oncology. Recurrent topics in Resham Bhattacharya's work include Nanoparticle-Based Drug Delivery (39 papers), Angiogenesis and VEGF in Cancer (21 papers) and Nanoplatforms for cancer theranostics (17 papers). Resham Bhattacharya is often cited by papers focused on Nanoparticle-Based Drug Delivery (39 papers), Angiogenesis and VEGF in Cancer (21 papers) and Nanoplatforms for cancer theranostics (17 papers). Resham Bhattacharya collaborates with scholars based in United States, Canada and Russia. Resham Bhattacharya's co-authors include Priyabrata Mukherjee, Rochelle R. Arvizo, Debabrata Mukhopadhyay, Chitta Ranjan Patra, Sanjib Bhattacharyya, Rachel A. Kudgus, Karuna Giri, J. David Robertson, Enfeng Wang and Vincent M. Rotello and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

Resham Bhattacharya

122 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future

2012 705 citations Rochelle R. Arvizo, Sanjib Bhattacharyya et al. Chemical Society Reviews profile →
Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond

2010 511 citations Rochelle R. Arvizo, Oscar R. Miranda et al. profile →
VEGF signaling: Role in angiogenesis and beyond

2024 92 citations Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya et al. profile →

Peers

Countries citing papers authored by Resham Bhattacharya

Since Specialization

Citations

This map shows the geographic impact of Resham Bhattacharya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Resham Bhattacharya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Resham Bhattacharya more than expected).

Fields of papers citing papers by Resham Bhattacharya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Resham Bhattacharya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Resham Bhattacharya. The network helps show where Resham Bhattacharya may publish in the future.

Co-authorship network of co-authors of Resham Bhattacharya

This figure shows the co-authorship network connecting the top 25 collaborators of Resham Bhattacharya. A scholar is included among the top collaborators of Resham Bhattacharya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Resham Bhattacharya. Resham Bhattacharya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A role for the cystathionine-β-synthase /H2S axis in astrocyte dysfunction in the aging brain 2023 ·Redox Biology ·Anindya Dey, (unknown), Shailendra Kumar Dhar Dwivedi, (unknown), Tamás Kiss, Abhrajit Ganguly, Heather C. Rice, Priyabrata Mukherjee, Chao Xu, Mohiuddin Ahmad, Anna Csiszár, Resham Bhattacharya	15
2	Small Non-Coding-RNA in Gynecological Malignancies 2021 ·Cancers ·(unknown), Geeta Rao, Anindya Dey, Priyabrata Mukherjee, Jonathan D. Wren, Resham Bhattacharya	30
3	Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis 2019 ·Molecular Cancer Research ·Deepika Neelakantan, Samrita Dogra, (unknown), (unknown), (unknown), Ralf Janknecht, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, (unknown), Kai Ding, Sukyung Woo	27
4	Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β 2019 ·Journal of Biological Chemistry ·Ying Wang, Luke H. Hoeppner, Ramcharan Singh Angom, Enfeng Wang, Shamit K. Dutta, (unknown), (unknown), Tao Shen, Isobel A. Scarisbrick, Sushovan Guha, Peter Störz, Resham Bhattacharya, Debabrata Mukhopadhyay	9
5	Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer 2018 ·Molecular Cancer Therapeutics ·(unknown), Anindya Dey, Shailendra Kumar Dhar Dwivedi, (unknown), Kai Ding, Roy Zhang, Priyabrata Mukherjee, Kathleen N. Moore, Liangxian Cao, Arthur Branstrom, Marla Weetall, John D. Baird, Resham Bhattacharya	14
6	Cystathionine β-Synthase Is Necessary for Axis Development in Vivo 2018 ·Frontiers in Cell and Developmental Biology ·Shubhangi Prabhudesai, (unknown), Anindya Dey, Shahram Eisa-Beygi, (unknown), Resham Bhattacharya, Priyabrata Mukherjee, Ramani Ramchandran	16
7	Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer 2017 ·Molecular Cancer Therapeutics ·Anindya Dey, Xunhao Xiong, (unknown), Shailendra Kumar Dhar Dwivedi, Soumyajit Banerjee Mustafi, Priyabrata Mukherjee, Liangxian Cao, Nadiya Sydorenko, Ramil Baiazitov, (unknown), Melissa Dumble, Thomas W. Davis, Resham Bhattacharya	31
8	MICU1 drives glycolysis and chemoresistance in ovarian cancer 2017 ·Nature Communications ·Prabir K. Chakraborty, Soumyajit Banerjee Mustafi, Xunhao Xiong, Shailendra Kumar Dhar Dwivedi, Vasyl Nesin, Sounik Saha, Min Zhang, Danny N. Dhanasekaran, Muralidharan Jayaraman, Robert S. Mannel, Kathleen N. Moore, Scott McMeekin, Da Yang, Rosemary E. Zuna, Kai Ding, Leonidas Tsiokas, Resham Bhattacharya, Priyabrata Mukherjee	137
9	MDR1 mediated chemoresistance: BMI1 and TIP60 in action 2016 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Soumyajit Banerjee Mustafi, Prabir K. Chakraborty, Sarwat Naz, Shailendra Kumar Dhar Dwivedi, (unknown), (unknown), Da Yang, Kai Ding, Priyabrata Mukherjee, Resham Bhattacharya	28
10	Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics 2013 ·PLoS ONE ·Rachel A. Kudgus, Annamária Szabolcs, Jameel Ahmad Khan, Chad A. Walden, Joel M. Reid, J. David Robertson, Resham Bhattacharya, Priyabrata Mukherjee	25
11	Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future breakdown → 2012 ·Chemical Society Reviews ·Rochelle R. Arvizo, Sanjib Bhattacharyya, Rachel A. Kudgus, Karuna Giri, Resham Bhattacharya, Priyabrata Mukherjee	705
12	Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer 2011 ·PLoS ONE ·Enfeng Wang, Sanjib Bhattacharyya, Annamária Szabolcs, Cristian Rodriguez‐Aguayo, Nicholas B. Jennings, Gabriel Lopez‐Berestein, Priyabrata Mukherjee, Anil K. Sood, Resham Bhattacharya	72
13	Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge 2011 ·Nanomedicine Nanotechnology Biology and Medicine ·Rochelle R. Arvizo, Subinoy Rana, Oscar R. Miranda, Resham Bhattacharya, Vincent M. Rotello, Priyabrata Mukherjee	189
14	Gold nanoparticles: opportunities and challenges in nanomedicine 2010 ·Expert Opinion on Drug Delivery ·Rochelle R. Arvizo, Resham Bhattacharya, Priyabrata Mukherjee	425
15	MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer 2009 ·Cancer Research ·Resham Bhattacharya, Milena S. Nicoloso, Rochelle R. Arvizo, Enfeng Wang, (unknown), Simona Rossi, George A. Calin, Priyabrata Mukherjee	206
16	Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer 2009 ·Advanced Drug Delivery Reviews ·Chitta Ranjan Patra, Resham Bhattacharya, Debabrata Mukhopadhyay, Priyabrata Mukherjee	334
17	Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent 2008 ·Cancer Research ·Chitta Ranjan Patra, Resham Bhattacharya, Enfeng Wang, (unknown), Julie S. Lau, Shamit K. Dutta, Michael H. Muders, Shanfeng Wang, Sarah A. Buhrow, Stephanie L. Safgren, Michael J. Yaszemski, Joel M. Reid, Matthew M. Ames, Priyabrata Mukherjee, Debabrata Mukhopadhyay	296
18	Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells 2008 ·Journal of Nanobiotechnology ·Christopher J. Gannon, Chitta Ranjan Patra, Resham Bhattacharya, Priyabrata Mukherjee, Steven A. Curley	202
19	Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis 2007 ·Journal of Nanobiotechnology ·Priyabrata Mukherjee, Resham Bhattacharya, Nancy D. Bone, (unknown), Chitta Ranjan Patra, Shanfeng Wang, Lichun Lu, Charla Secreto, Pataki C. Banerjee, Michael J. Yaszemski, Neil E. Kay, Debabrata Mukhopadhyay	165
20	Expression and Regulatory Role of GAIP-Interacting Protein GIPC in Pancreatic Adenocarcinoma 2006 ·Cancer Research ·Michael H. Muders, Shamit K. Dutta, Ling Wang, Julie S. Lau, Resham Bhattacharya, Thomas C. Smyrk, Suresh T. Chari, Kaustubh Datta, Debabrata Mukhopadhyay	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact